ArticleBMC cancer2016

Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells.

Yan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.